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It has been an exceptional year for Jefferson Medical College’s (JMC) Department of 
Health Policy. In December 2003, the Office of Health Policy was elevated to the status of 
a full academic department within the medical school.  Concurrently, David B. Nash, MD, 
MBA, who founded the original Office of Health Policy in 1990, was named the Dr. 
Raymond C. and Doris N. Grandon Chair of the new department. A white coat procession 
of JMC chairs was held this spring in honor of his investiture. This year, Dr. Nash was also 
appointed co-director of Jefferson’s new Master of Science in Public Health program, along 
with Richard C. Wender, MD, of the Department of Family Medicine. 
 
As the Department of Health Policy grows, it continues to provide venues for discussion of 
important and timely health policy issues. This past spring and summer, the Department 
hosted the 13th Annual Grandon Lecture, the 4th Annual Disease Management 
Colloquium, and the 10th Annual Summer Seminar. Following are highlights from these 
events. 
Department of Health Policy   
 Events 
Aetna Chief Delivers Grandon Lecture 
 
On May 6th, John W. Rowe, MD, Chairman and CEO of Aetna, Inc., the nation’s largest 
health insurer, presented the 13thAnnual Raymond C. Grandon Lecture at Thomas 
Jefferson University. His talk was entitled “Health Care Costs: Why Are They Rising?” 
 
Health care costs continue to increase at double-digit rates. Dr. Rowe pointed to hospital 
services as the leading driver of rising costs, accounting for more than half of the overall 
spending increase. Employers are shifting more and more of these costs to workers, 
primarily through higher deductibles and higher prescription drug co-payments. 
 
Dr. Rowe examined several emerging strategies among government and employers to 
improve health care purchasing and control spiraling costs. Last year, the Bush 
Administration signed into law the Medicare Prescription Drug, Improvement and 
Modernization Act, the biggest overhaul of Medicare in its 38-year history. According to 
Dr. Rowe, one of the most significant changes in this new legislation is a provision 
establishing Health Savings Accounts (HSAs), tax-free accounts designed to help 
employees save and pay for health care expenses. 
 
Employers meanwhile are demanding better quality of care through organizations such as 
The Leapfrog Group, a national coalition of health care purchasers dedicated to promoting 
improvements in patient safety. In addition, they are beginning to give their employees 
increased responsibility in health care decisions and financing. More employers are now 
offering consumer-driven health plans, where workers manage their own health care 
benefits and spending. These plans are proving to have a significant impact on quality and 
cost, said Dr. Rowe. A recent study shows members of Aetna’s consumer-driven plan 
HealthFund are helping to drive down health care and pharmaceutical costs by seeking 
increased preventive care and taking greater advantage of health care tools and 
information.  
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Following Dr. Rowe’s talk, a reactor panel provided a broad range of perspectives on the 
topic of rising health care costs, addressing such issues as tort reform and its effect on the 
marketplace, the increasing demands of aging baby boomers, the impact of new 
pharmaceuticals on health expenditures, and patient decision-making in underprivileged 
populations. The panel included, from Thomas Jefferson University Hospital, Neil Lubarsky, 
Senior Vice President, and Jay Sial, Vice President, Managed Care Contracting and 
Financial Planning, and Chief Operating Officer, JeffCARE, Inc; from Thomas Jefferson 
University, George Valko, MD, Medical Director, Department of Family Medicine, and 
Michael Vergare, MD, Chairman, Department of Psychiatry and Human Behavior; and 
Barry Freedman, President and CEO, Albert Einstein Health Care Network. 
 
The Grandon lecture series is funded through a gift by Raymond C. Grandon, MD (JMC 
‘45). A renowned internist with a special interest in cardiovascular care, Dr. Grandon was 
a clinical investigator of cardio-active drugs and helped to coordinate the nation’s first 
commercially successful cardiac rehabilitation program. Dr. Grandon is former president of 
the Pennsylvania Medical Society and has served the state of Pennsylvania and the 
nation’s medical community in a variety of advisory and regulatory capacities over the 
course of his long career. Currently, Dr. Grandon is president of the Central Pennsylvania 
Chapter of the Jefferson Medical College Alumni Association and a member of the 
Department of Health Policy Advisory Board. 
 
4th Annual Disease Management Colloquium Held on  
Jefferson Campus 
 
Over two hundred health care professionals gathered on the Jefferson campus this 
summer to attend the 4th Annual Disease Management Colloquium. The June 27-30 event 
examined the role that disease management (DM) plays in Medicare and Medicaid, 
healthcare cost efficiency, quality and medical errors reduction. 
 
The conference featured talks by over 30 leading experts in this rapidly growing field. In 
an opening presentation, Dr. David Nash, Chair of the Department of Health Policy, set the 
stage with his discussion of “The Emerging Role of Disease Management as a Major Driver 
in a Reformed 21st Century Health System.” Dr. Nash presented recent case studies of DM 
efforts, outlined strategies for successfully managing chronic illnesses, and described the 
cultural challenges facing DM programs, such as physicians’ reluctance to adopt an 
evidence-based approach to their practice of medicine.  Aetna Chief Delivers Grandon 
Lecture 4th Annual Disease Management Colloquium Held on Jefferson Campus 
 
According to speaker Paul Keckley, PhD, most providers do not practice evidence-based 
medicine (EBM), resulting in deficiencies in preventive and chronic care and other serious 
quality gaps in the health care system. In his presentation on “Incorporating Evidence-
Based Medicine into Disease Management Programs,” Keckley, Senior Fellow, Vanderbilt 
Center for Better Health, and Founder and Senior Advisor, EBM Solutions, discussed the 
implications of EBM for disease management providers. Looking ahead, he described an 
evidence-based care management model of the future that includes incentives for 
collaborative care, better use of information technology, and more engaged consumers. 
 
A number of speakers addressed the benefits of DM in Medicaid and Medicare programs. 
Stuart Guterman, PhD, Director, Office of Research, Development and Information, 
Centers for Medicare and Medicaid Services (CMS), described several CMS demonstration 
projects underway designed to explore new ways of providing DM services to Medicare 
Miriam Reisman:  Department of Health Policy Update and Highlights of Special Events 
Health Policy Newsletter Vol. 17, No. 3 (September 2004), Article 10 
beneficiaries. One contributing factor to the success of any DM program, he said, is the 
implementation of a sophisticated data system to better monitor and manage the care of 
patients. In another presentation, a panel of experts discussed efforts to incorporate DM 
services into state Medicaid programs. Louis Rossiter, PhD, Senior Research Fellow, The 
College of William and Mary, examined innovative state-run DM programs around the 
country, which, he said, have the potential to redefine the standard of care in Medicaid. 
 
One of the highlights of the Colloquium was a CEO panel discussion featuring executives 
from American Healthways, Health Dialog, CorSolutions, and other leading providers of 
disease and care management services. Panelists discussed the challenges of 
implementing disease management programs and strategies for success. All agreed that 
technology will continue to be a significant component in disease management and 
emphasized the importance of providing physicians and other providers with technological 
support to better manage clinical information about their patients and contain the costs of 
health care. 
 
Summer Seminar:  The Medicare Modernization Act 
 
On December 8, 2003, the Medicare Prescription Drug, Improvement and Modernization 
Act was signed into law. Now known as the Medicare Modernization Act (MMA), this 
landmark legislation includes significant changes to the Medicare program, including the 
addition of a prescription drug benefit for millions of older and disabled Americans. In an 
effort to answer the many questions surrounding these changes, the Department of Health 
Policy invited five prominent experts on the topic, representing the major stakeholders, to 
speak at the 10th Annual Summer Seminar, held July 16th at the Hotel Sofitel in 
Philadelphia. 
 
Larry Goldberg, Director of Washington National Affairs Health Care for Deloitte & Touche 
LLP, opened the seminar with an overview of the MMA. He examined key elements of the 
bill, including a new Medicare Part D drug benefit for outpatient prescription drug coverage 
to begin January 1, 2006, and the prescription drug discount card, which became effective 
this past June. 
 
Given the rising drug prices, these discounts may not be enough, according to speaker 
John Rother, Director, Legislation and Public Policy, AARP. Rother questioned the overall 
value of the drug benefit for consumers, especially older individuals, who are having an 
increasingly difficult time affording medications.  The AARP supported the MMA because it 
does help low-income Medicare beneficiaries; however, Rother said, it is critical to start an 
effort to get prescription drug costs under control. 
 
Providing a political backdrop to the MMA, Charles Kahn, President of the Federation of the 
American Hospitals, said that while the new legislation has had a rocky start, it has been 
wrongly aligned. Kahn, a nationally known health policy expert with many years of 
experience on Capitol Hill, described the MMA as a “political pawn in a world of perpetual 
attack.”  Despite the Democrats’ criticism of the MMA, said Kahn, it is an extremely 
important expansion of the Medicare program, one that provides beneficiaries with long-
needed prescription drug coverage and better enables America’s hospitals to provide 
quality care to seniors. 
 
Speaker David Shulke, Executive Vice President of the American Health Quality 
Association, examined several of the quality provisions contained in the MMA, including 
the electronic prescription program, submission of hospital quality data, and quality 
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improvement organizations (QIOs), a network of private organizations that work with 
consumers, physicians, hospitals, and other caregivers to refine care delivery systems.  
Under the new Medicare legislation, he said, the work of QIOs will expand to include such 
efforts as the prevention of surgical complications and improvement in ambulatory drug 
therapy. 
 
In the final presentation, Richard Smith, Vice President, Policy and Research, PhRMA, 
provided the pharmaceutical industry's perspective of the Medicare Modernization Act by 
first addressing the debate over rising drug costs. According to Smith, prescription drug 
prices have increased at about the same rate as other health care services since the 
Medicare bill was signed into law. Defending the discount drug card, Smith said the focus 
now should not be on controlling drug costs, but on providing Medicare beneficiaries with 
affordable access to the newest and most effective medications. 
 
Following the presentations, a panel of representatives from the pharmaceutical industry 
responded to the talks and discussed related issues, such as the importance of designing 
quality initiatives that demonstrate the effectiveness of specific drugs and the need to 
develop tools to measure health outcomes of Medicare beneficiaries. 
 
For more information on these events, as well as upcoming Department activities, please 
call 215-955-6969, or visit www.jefferson.edu/dhp. 
 
About the Author 
 
Miriam Reisman is the Managing Editor of the Health Policy Newsletter for the Department 
of Health Policy at Thomas Jefferson University. 
 
